These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35908628)

  • 1. 5-Aza-dC promotes T-cell acute lymphoblastic leukemia cell invasion via downregulation of DNMT1 and upregulation of MMP-2 and MMP-9.
    Lin C; Xie Y; Huang W; Lin D; Lin L
    Exp Hematol; 2022 Oct; 114():43-53.e2. PubMed ID: 35908628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-aza-2'-deoxycytidine-induced genome rearrangements are mediated by DNMT1.
    Maslov AY; Lee M; Gundry M; Gravina S; Strogonova N; Tazearslan C; Bendebury A; Suh Y; Vijg J
    Oncogene; 2012 Dec; 31(50):5172-9. PubMed ID: 22349820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells.
    Vispé S; Deroide A; Davoine E; Desjobert C; Lestienne F; Fournier L; Novosad N; Bréand S; Besse J; Busato F; Tost J; De Vries L; Cussac D; Riond J; Arimondo PB
    Oncotarget; 2015 Jun; 6(17):15265-82. PubMed ID: 25948775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of 5-aza-2'-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme.
    Patel K; Dickson J; Din S; Macleod K; Jodrell D; Ramsahoye B
    Nucleic Acids Res; 2010 Jul; 38(13):4313-24. PubMed ID: 20348135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4'-thio-2'-deoxycytidine and 5-aza-4'-thio-2'-deoxycytidine.
    Thottassery JV; Sambandam V; Allan PW; Maddry JA; Maxuitenko YY; Tiwari K; Hollingshead M; Parker WB
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):291-302. PubMed ID: 24908436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation-mediated silencing of microRNA-204 enhances T cell acute lymphoblastic leukemia by up-regulating MMP-2 and MMP-9 via NF-κB.
    Lin C; Chen D; Xiao T; Lin D; Lin D; Lin L; Zhu H; Xu J; Huang W; Yang T
    J Cell Mol Med; 2021 Mar; 25(5):2365-2376. PubMed ID: 33566449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-aza-2'-Deoxycytidine, a DNA methyltransferase inhibitor, facilitates the inorganic phosphorus-induced mineralization of vascular smooth muscle cells.
    Azechi T; Sato F; Sudo R; Wachi H
    J Atheroscler Thromb; 2014; 21(5):463-76. PubMed ID: 24441913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors.
    Laranjeira ABA; Hollingshead MG; Nguyen D; Kinders RJ; Doroshow JH; Yang SX
    Sci Rep; 2023 Apr; 13(1):5964. PubMed ID: 37045940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant DNA methylation-induced gene inactivation is associated with the diagnosis and/or therapy of T-cell leukemias.
    Kim SY; Shin DY; Kim SM; Lee M; Kim EJ
    Leuk Res; 2016 Aug; 47():116-22. PubMed ID: 27318093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aza-2'-deoxycytidine, a DNA methylation inhibitor, induces cytotoxicity, cell cycle dynamics and alters expression of DNA methyltransferase 1 and 3A in mouse hippocampus-derived neuronal HT22 cells.
    Yang J; Tian X; Yang J; Cui J; Jiang S; Shi R; Liu Y; Liu X; Xu W; Xie W; Jia X; Bade R; Zhang T; Zhang M; Gong K; Yan S; Yang Z; Shao G
    J Toxicol Environ Health A; 2017; 80(22):1222-1229. PubMed ID: 28880816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-aza-2'-deoxycytidine induces alterations in murine spermatogenesis and pregnancy outcome.
    Kelly TL; Li E; Trasler JM
    J Androl; 2003; 24(6):822-30. PubMed ID: 14581508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs.
    Oshima G; Poli EC; Bolt MJ; Chlenski A; Forde M; Jutzy JMS; Biyani N; Posner MC; Pitroda SP; Weichselbaum RR; Khodarev NN
    Cancer Res; 2019 Feb; 79(3):650-662. PubMed ID: 30538122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal.
    Ghoshal K; Datta J; Majumder S; Bai S; Kutay H; Motiwala T; Jacob ST
    Mol Cell Biol; 2005 Jun; 25(11):4727-41. PubMed ID: 15899874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells.
    Yan F; Shen N; Pang J; Molina JR; Yang P; Liu S
    J Biol Chem; 2015 Jul; 290(30):18480-94. PubMed ID: 26085088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Aza-4'-thio-2'-deoxycytidine, a New Orally Bioavailable Nontoxic "Best-in-Class": DNA Methyltransferase 1-Depleting Agent in Clinical Development.
    Parker WB; Thottassery JV
    J Pharmacol Exp Ther; 2021 Nov; 379(3):211-222. PubMed ID: 34503994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-aza-2'-deoxycytidine leads to reduced embryo implantation and reduced expression of DNA methyltransferases and essential endometrial genes.
    Ding YB; Long CL; Liu XQ; Chen XM; Guo LR; Xia YY; He JL; Wang YX
    PLoS One; 2012; 7(9):e45364. PubMed ID: 23028963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacodynamic assay to monitor treatment with the hypomethylating cytosine analogs, decitabine and azacitidine.
    Jacobberger JW; Woost PG
    Methods Cell Biol; 2024; 186():131-150. PubMed ID: 38705597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DNA hypomethylating agent, 5-aza-2'-deoxycytidine, enhances tumor cell invasion through a transcription-dependent modulation of MMP-1 expression in human fibrosarcoma cells.
    Poplineau M; Schnekenburger M; Dufer J; Kosciarz A; Brassart-Pasco S; Antonicelli F; Diederich M; Trussardi-Régnier A
    Mol Carcinog; 2015 Jan; 54(1):24-34. PubMed ID: 24038389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancer DNMT1 expression and sensitivity to DNMT1 inhibitors.
    Li A; Omura N; Hong SM; Goggins M
    Cancer Biol Ther; 2010 Feb; 9(4):321-9. PubMed ID: 20234167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
    Lin HY; Kuo YC; Weng YI; Lai IL; Huang TH; Lin SP; Niu DM; Chen CS
    Prostate; 2012 Dec; 72(16):1767-78. PubMed ID: 22539223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.